119 related articles for article (PubMed ID: 25131810)
1. Overexpression of EZH2 associates with a poor prognosis in chronic lymphocytic leukemia.
Rabello Ddo A; Lucena-Araujo AR; Alves-Silva JC; da Eira VB; de Vasconcellos MC; de Oliveira FM; Rego EM; Saldanha-Araujo F; Pittella Silva F
Blood Cells Mol Dis; 2015 Jan; 54(1):97-102. PubMed ID: 25131810
[TBL] [Abstract][Full Text] [Related]
2. The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia.
Papakonstantinou N; Ntoufa S; Chartomatsidou E; Kotta K; Agathangelidis A; Giassafaki L; Karamanli T; Bele P; Moysiadis T; Baliakas P; Sutton LA; Stavroyianni N; Anagnostopoulos A; Makris AM; Ghia P; Rosenquist R; Stamatopoulos K
Oncotarget; 2016 Jun; 7(24):35946-35959. PubMed ID: 27191993
[TBL] [Abstract][Full Text] [Related]
3. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
[TBL] [Abstract][Full Text] [Related]
4. Unraveling KDM4 histone demethylase expression and its association with adverse cytogenetic findings in chronic lymphocytic leukemia.
Filiú-Braga LDC; Serejo TRT; Lucena-Araujo AR; Neves FAR; de Carvalho JL; Rego EM; Saldanha-Araujo F
Med Oncol; 2018 Nov; 36(1):3. PubMed ID: 30426231
[TBL] [Abstract][Full Text] [Related]
5. GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death.
Alves-Silva JC; de Carvalho JL; Rabello DA; Serejo TRT; Rego EM; Neves FAR; Lucena-Araujo AR; Pittella-Silva F; Saldanha-Araujo F
Invest New Drugs; 2018 Oct; 36(5):955-960. PubMed ID: 29855824
[TBL] [Abstract][Full Text] [Related]
6. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.
Dürig J; Nückel H; Cremer M; Führer A; Halfmeyer K; Fandrey J; Möröy T; Klein-Hitpass L; Dührsen U
Leukemia; 2003 Dec; 17(12):2426-34. PubMed ID: 14523469
[TBL] [Abstract][Full Text] [Related]
7. Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients.
Monserrat J; Sánchez MÁ; de Paz R; Díaz D; Mur S; Reyes E; Prieto A; de la Hera A; Martínez-A C; Alvarez-Mon M
Cytometry B Clin Cytom; 2014 Jan; 86(1):32-43. PubMed ID: 24166938
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
[TBL] [Abstract][Full Text] [Related]
9. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.
Bosch F; Muntañola A; Giné E; Carrió A; Villamor N; Moreno C; Crespo M; Montserrat E
Cytometry B Clin Cytom; 2006 Jul; 70(4):214-7. PubMed ID: 16906580
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
12. Variability of ZAP 70 expression in a patient with CLL.
Chaar BT; Grosso L; Petruska PJ
Am J Hematol; 2006 Aug; 81(8):645. PubMed ID: 16823829
[No Abstract] [Full Text] [Related]
13. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
[TBL] [Abstract][Full Text] [Related]
14. Aberrant differential expression of EZH1 and EZH2 in Polycomb repressive complex 2 among B- and T/NK-cell neoplasms.
Abdalkader L; Oka T; Takata K; Sato H; Murakami I; Otte AP; Yoshino T
Pathology; 2016 Aug; 48(5):467-82. PubMed ID: 27311868
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors.
Tavolaro S; Chiaretti S; Messina M; Peragine N; Del Giudice I; Marinelli M; Santangelo S; Mauro FR; Guarini A; Foà R
Leuk Res; 2010 Jun; 34(6):733-41. PubMed ID: 20036005
[TBL] [Abstract][Full Text] [Related]
17. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
[TBL] [Abstract][Full Text] [Related]
18. Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.
Huang L; Chen S; Zha X; Yang L; Li B; Yu Z; Wang L; Li Y
Hematology; 2012 Mar; 17(2):71-5. PubMed ID: 22664044
[TBL] [Abstract][Full Text] [Related]
19. Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia.
Carvalho Alves-Silva J; do Amaral Rabello D; Oliveira Bravo M; Lucena-Araujo A; Madureira de Oliveira D; Morato de Oliveira F; Magalhaes Rego E; Pittella-Silva F; Saldanha-Araujo F
Environ Mol Mutagen; 2017 Dec; 58(9):654-661. PubMed ID: 28833505
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
